FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,535,459 | -29.9% | 724,273 | +57.4% | 0.00% | -100.0% |
| Q2 2023 | $2,190,942 | +304.5% | 460,282 | +384.4% | 0.00% | – |
| Q1 2023 | $541,660 | -65.4% | 95,028 | -38.7% | 0.00% | -100.0% |
| Q4 2022 | $1,563,416 | +485.5% | 154,947 | +1199.5% | 0.00% | – |
| Q3 2022 | $267,000 | -51.5% | 11,924 | -46.3% | 0.00% | – |
| Q2 2022 | $550,000 | -59.7% | 22,195 | -36.9% | 0.00% | – |
| Q1 2022 | $1,365,000 | -78.5% | 35,200 | -67.5% | 0.00% | -100.0% |
| Q4 2021 | $6,338,000 | +244.3% | 108,335 | +248.7% | 0.00% | – |
| Q3 2021 | $1,841,000 | -35.3% | 31,064 | -5.2% | 0.00% | -100.0% |
| Q2 2021 | $2,845,000 | -39.6% | 32,776 | -42.7% | 0.00% | -50.0% |
| Q1 2021 | $4,714,000 | -22.4% | 57,174 | -14.4% | 0.00% | -33.3% |
| Q4 2020 | $6,073,000 | +248.6% | 66,788 | +53.3% | 0.00% | +200.0% |
| Q3 2020 | $1,742,000 | +200.9% | 43,575 | +158.1% | 0.00% | – |
| Q2 2020 | $579,000 | +135.4% | 16,882 | +52.5% | 0.00% | – |
| Q1 2020 | $246,000 | +1.7% | 11,071 | -28.9% | 0.00% | – |
| Q3 2019 | $242,000 | -21.7% | 15,562 | +2.1% | 0.00% | -100.0% |
| Q2 2019 | $309,000 | +76.6% | 15,242 | +11.6% | 0.00% | – |
| Q4 2018 | $175,000 | +6.1% | 13,656 | +34.8% | 0.00% | – |
| Q3 2018 | $165,000 | +42.2% | 10,127 | -0.8% | 0.00% | – |
| Q2 2018 | $116,000 | +157.8% | 10,213 | -9.6% | 0.00% | – |
| Q3 2017 | $45,000 | -41.6% | 11,292 | -7.4% | 0.00% | -100.0% |
| Q2 2014 | $77,000 | -33.6% | 12,200 | +2.5% | 0.00% | 0.0% |
| Q1 2014 | $116,000 | – | 11,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |